CCCC
#2954
C4 Therapeutics, Inc. - Common Stock
3.8 5 USD
-0.06%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-6.10%
Variación mensual
+9.07%
Variación en los últimos 6 meses
+47.51%
Cambio anual
+49.81%
Cierres anteriores
4.1 0
Open
3.8 4
Mínimo
3.8 4
Máximo
3.8 5
Volumen
73
Financials
- Market Capitalization 473.65 M
- Employee 104
- Founded 2015
- CEO N/A
- Website www.c4therapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00BV2Y9B7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.5
Relación precio/flujo de caja
4.4
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2943 |  EVMN Evommune, Inc. Common Stock | 13.22 USD | -1.56% | -3.36% | +20.95% | -23.67% | 479.78 M USD | ||
| 2944 |  PRTA Prothena Corporation plc - Ordinary Shares | 9.33 USD | +2.64% | -1.37% | +9.76% | +14.20% | 478.97 M USD | ||
| 2959 |  PBYI Puma Biotechnology Inc - Common Stock | 9.06 USD | -1.95% | -2.58% | +16.30% | +79.41% | 467.68 M USD | ||
| 2968 |  RLMD Relmada Therapeutics, Inc. - Common Stock | 4.33 USD | -4.20% | -6.68% | -17.05% | +283.19% | 461.88 M USD |